Also, both bone-metastatic myeloma and breast cancer cells are able to stimulate the production of IL-6 by bone marrow stromal cells, resulting in increased osteoclast differentiation and bone destruction [48, 49]. This evidence concerns the gene IL6 and plasma cell myeloma.